Wall Street slips on tech sector weakness
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/7/2026
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- U.S. economy adds 172,000 jobs in May, topping expectations
- Citi warns global stock markets are the frothiest since 2008
- JPMorgan upgrades Tesla, sets new price target on robotaxi and Optimus potential
- Fed risks fueling a stock bubble by overlooking AI-driven inflation: BCA
- Earthquake of magnitude 8.2 strikes Mindanao, Philippines, GFZ says
- Wall Street ends sharply lower as chips slide, jobs data fuels rate hike fears
- Marvell Technology and Flex to join S&P 500; others to join S&P MidCap 400 and S&P SmallCap 600
- SpaceX signs $920 million monthly cloud deal with Google
- Target recalls Up & Up baby wipes due to bacterial contamination
Apple (AAPL) PT Maintained at $195 at Wells Fargo; 'China Mobile Phone Export Data Reinforces Cautious Opinion on iPhone Cycle'
December 28, 2017 5:58 AM ESTWells Fargo maintained its price target on Apple (NASDAQ: AAPL) at $195.00 while maintaining a Market Perform rating, following a review of the company's iPhone-related data out of China.
Analyst Aaron Rakers notes a cautious outlook on the company's iPhone cycle in China, citing mobile phone export data out this week that... More
Sucampo Pharma (SCMP) Ticks Above Takeover Price
December 26, 2017 12:48 PM ESTSucampo Pharma (NASDAQ: SCMP) has ticked above Mallinckrodt's $18 per share acquisition price. SCMP last at $18.05. Speculators cite the relatively low $44 million break-up fee.
... MoreMallinckrodt's (MNK) Sucampo Acquisition 'Is A Smart Strategic Deal' - Cantor Fitzgerald
December 26, 2017 11:42 AM ESTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $42 price target on Mallinckrodt plc (NYSE: MNK) following the strategic deal to acquire Sucampo (NASDAQ: SCMP) for $1.2 billion.
Chen said she likes the deal because it brings a... More
Maxim Group Downgrades Sucampo Pharmaceuticals (SCMP) to Hold Following Acquisition; Sees Low Probability of Another Bidder
December 26, 2017 10:46 AM ESTMaxim Group downgraded Sucampo Pharmaceuticals (NASDAQ: SCMP) from Buy to Hold after the company agreed to be acquired.
"We understand there is a nominal breakup fee which leaves the door open for another bidder, though we see this as low probability," analyst Jason... More
Sucampo Pharma (SCMP) Discloses $44M Merger Termination Fee
December 26, 2017 7:57 AM ESTSucampo Pharma (NASDAQ: SCMP) disclosed that it will pay Mallinckrodt (NYSE: MNK) a termination fee of $44 million if it terminates the merger agreement, including a termination by Sucampo to enter into an agreement for an alternative transaction that constitutes a "Superior Offer."
... More